| Product Code: ETC7656547 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Multiple Myeloma Diagnostic Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Multiple Myeloma Diagnostic Market - Industry Life Cycle |
3.4 Israel Multiple Myeloma Diagnostic Market - Porter's Five Forces |
3.5 Israel Multiple Myeloma Diagnostic Market Revenues & Volume Share, By Product Types, 2021 & 2031F |
3.6 Israel Multiple Myeloma Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Israel Multiple Myeloma Diagnostic Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Israel Multiple Myeloma Diagnostic Market Revenues & Volume Share, By End user, 2021 & 2031F |
3.9 Israel Multiple Myeloma Diagnostic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Multiple Myeloma Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple myeloma in Israel |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Technological advancements in diagnostic tools for multiple myeloma |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure in certain regions of Israel |
4.3.2 Stringent regulatory requirements for diagnostic products |
4.3.3 High cost associated with advanced diagnostic tests |
5 Israel Multiple Myeloma Diagnostic Market Trends |
6 Israel Multiple Myeloma Diagnostic Market, By Types |
6.1 Israel Multiple Myeloma Diagnostic Market, By Product Types |
6.1.1 Overview and Analysis |
6.1.2 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Product Types, 2021- 2031F |
6.1.3 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Multiple Myeloma Suppression, 2021- 2031F |
6.1.4 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Multiple Myeloma Treatment, 2021- 2031F |
6.2 Israel Multiple Myeloma Diagnostic Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Devices, 2021- 2031F |
6.2.3 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Consumables, 2021- 2031F |
6.2.4 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.3 Israel Multiple Myeloma Diagnostic Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Smouldering (Indolent) Multiple Myeloma, 2021- 2031F |
6.3.3 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Active (Symptomatic) Multiple Myeloma, 2021- 2031F |
6.3.4 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Solitary Plasmacytoma of the Bone, 2021- 2031F |
6.3.5 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Extramedullary Plasmacytoma, 2021- 2031F |
6.3.6 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Multiple Myeloma Diagnostic Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Multiple Myeloma Diagnostic Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Israel Multiple Myeloma Diagnostic Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Israel Multiple Myeloma Diagnostic Market Import-Export Trade Statistics |
7.1 Israel Multiple Myeloma Diagnostic Market Export to Major Countries |
7.2 Israel Multiple Myeloma Diagnostic Market Imports from Major Countries |
8 Israel Multiple Myeloma Diagnostic Market Key Performance Indicators |
8.1 Average time taken for diagnosis of multiple myeloma |
8.2 Adoption rate of new diagnostic technologies in Israel |
8.3 Number of healthcare facilities offering multiple myeloma diagnostic services |
8.4 Patient survival rates post early diagnosis and treatment |
8.5 Rate of misdiagnosis in multiple myeloma cases |
9 Israel Multiple Myeloma Diagnostic Market - Opportunity Assessment |
9.1 Israel Multiple Myeloma Diagnostic Market Opportunity Assessment, By Product Types, 2021 & 2031F |
9.2 Israel Multiple Myeloma Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Israel Multiple Myeloma Diagnostic Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Israel Multiple Myeloma Diagnostic Market Opportunity Assessment, By End user, 2021 & 2031F |
9.5 Israel Multiple Myeloma Diagnostic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Multiple Myeloma Diagnostic Market - Competitive Landscape |
10.1 Israel Multiple Myeloma Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Israel Multiple Myeloma Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here